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and fibrosis. qRT-PCR and northern blot analysis revealed 
that RAP caused a marked increase in the expression of 
miR-21. Transfection with a miR-21 inhibitor significantly 
increased the expression of Smad7, while the expression 
of collagen I/III significantly decreased. These changes 
were implicated in the AF-induced release of miR-21 and 
down-regulation of Smad7. Adult rat cardiac fibroblasts 
treated with TGF-β1 showed increased miR-21 expres-
sion and decreased Smad7 expression. Pretreatment with 
a TGF-β1 inhibitor reduced the TGF-β1-induced up-reg-
ulation of miR-21. Pretreatment with pre-miR-21 and a 
miR-21 inhibitor significantly decreased and increased 
Smad7 expression, respectively. This result was negatively 
correlated with the expression of collagen I/III in fibro-
blasts. Moreover, the results of a luciferase activity assay 
suggest that Smad7 is a validated miR-21 target in CFs. 
Our results provide compelling evidence that the miR-21 
specific degradation of Smad7 may decrease the inhibi-
tory feedback regulation of TGF-β1/Smad signaling and 
serves as a new insight of the mechanism of atrial fibrosis 
in atrial fibrillation.
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Introduction
Atrial fibrillation (AF) is one of the most common cardiac 
arrhythmias and remains a major contributor to morbidity 
and mortality in clinical practice [1, 2]. Myocardial fibrosis 
plays a key role in the development and maintenance of AF 
[3, 4]. A better understanding of the mechanisms underly-
ing myocardial fibrosis in AF may contribute to the more 
effective prevention and treatment of AF in the future.
Abstract Tachycardia-induced atrial fibrosis is a hall-
mark of the structural remodeling of atrial fibrillation 
(AF). The mechanisms underlying tachycardia-induced 
atrial fibrosis remain unclear. In our previous study, we 
found that Smad7-downregulation promoted the develop-
ment of atrial fibrosis in AF. Fibroblasts are enriched in 
microRNA-21 (miR-21), which contributes to the devel-
opment of fibrosis and heart failure in the cardiovascular 
system. Our study was designed to test the hypothesis that 
miR-21 reinforces the TGF-β1/Smad signaling pathway 
in AF-induced atrial fibrosis by down-regulating Smad7. 
Rapid atrial pacing (RAP, 1000 ppm) was applied to the 
left atrium of the rabbit heart to induce atrial fibrillation 
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Myocardial fibrosis has been proved to be the main 
cause of atrial fibrillation [3, 5]. Atrial fibrosis causes intra- 
and inter-atrial inhomogeneity in conduction, thus creating 
a substrate for local re-entry and contributing to the main-
tenance and progression of AF [6–8]. Our previous study 
clearly indicated that atrial fibrosis plays an important role 
in the induction and perpetuation of AF [9, 10]. The trans-
forming growth factor-β1 (TGF-β1)/Smad signaling path-
way is one of the most classic signaling pathways involved 
in the regulation of fibrosis [9, 10]. In the pathological con-
ditions of AF, TGF-β1 synthesis and secretion is increased 
[3, 10, 11]. Activated TGF-β1 binds to membrane-bound 
heteromeric receptor kinases (TβRI and TβRII) that trans-
duce intracellular signals via both Smad and non-Smad 
pathways. Activated TβRI and TβRII receptors phosphoryl-
ate receptor regulated Smads (R-Smads, such as Smad2/3), 
which form homomeric complexes and heteromeric com-
plexes with a co-Smad (Smad4) [8, 9, 12]. These acti-
vated Smad complexes translocate into the nucleus, where 
they accumulate and bind to target genes to directly regu-
late their transcription and the production of related pro-
teins such as fibrin [5, 8]. The inhibitory Smad proteins 
(I-Smads, such as Smad6/7) are capable of inhibiting TGF-
β1 signaling. Smad7 binds to activated TβRI and prevents 
the phosphorylation of Smad2/3 or recruits the ubiquitin 
ligases Smurf1 and Smurf2 to induce proteasomal degra-
dation of the receptor complexes. Therefore, Smad7 may 
act as a major negative regulator, forming autoinhibitory 
feedback loops in the TGF-β1/Smad2/3 signaling pathway 
[11, 12]. We previously reported that the high expression of 
TGF-β1 in pathological conditions could cause the down-
regulation of Smad7, which contributes to the development 
of myocardial fibrosis in AF [10]. However, the molecular 
mechanism of the regulation of Smad7 expression through 
TGF-β1 remains unclear in AF.
MicroRNAs (miRNAs) are a broad class of small non-
coding RNAs that control the expression of complementary 
target messenger RNAs. MicroRNA-21 (miR-21) is con-
sistently reported to be upregulated in both cancer and vari-
ous forms of cardiovascular disease [13, 14]. Fibroblasts in 
the cardiovascular system are enriched in miR-21, which 
contributes to the development of fibrosis and heart failure 
[15]. miR-21 has therefore emerged as an interesting can-
didate for the development of therapeutic strategies against 
many forms of heart disease. The inhibition of miR-21 by 
synthetic miRNA antagonists improved heart function in a 
cardiac disease model [16–19]. The same beneficial effects 
were observed in miR-21 knockout mice subjected to pres-
sure-overload of the left ventricle, underlining the poten-
tial of miR-21 as a therapeutic target [20]. In recent years, 
additional roles of miR-21 in cardiovascular and pulmonary 
diseases have been described, including cardiac and pulmo-
nary fibrosis as well as myocardial infarction [21–23]. It 
has been reported that TGF-β1 can increase miR-21 expres-
sion in cardiac fibroblasts and may be involved in the regu-
lation of myocardial fibrosis [22, 24]. Animal experiments 
found that miR-21 expression affected the TGF-β1-induced 
renal tubular epithelial-to-mesenchymal transition in dia-
betic nephropathy by regulating Smad7 [25]. However, 
mechanistic data on the relationship between miR-21 and 
the TGF-β1/Smad7 signaling pathway in AF are still miss-
ing. In the present study, our aim was to determine if miR-
21 up-regulation could enhance TGF-β1-induced myocar-
dial fibrosis by inhibiting Smad7.
Materials and methods
Ethical standards
This study complied with the Declaration of Helsinki and 
the ethics committee of Guangdong Cardiovascular Insti-
tute, Guangdong General Hospital approved the study pro-
tocol. Informed consent from all participants was obtained 
before the initial coronary angiography. All of the experi-
mental procedures were performed according to the Guide 
for the Care and Use of Laboratory Animals (NIH Publica-
tion No. 85-23, revised 1996) and were in compliance with 
the guidelines specified by the Chinese Heart Association 
policy on research animal use and the Public Health Ser-
vice policy on the use of laboratory animals.
Animals
Male New Zealand rabbits (2.0–2.5 kg) were randomly 
divided into 4 groups (n = 10 for each group): normal con-
trol (CR), sham control (SH), rapid atrial pacing (RAP) and 
RAP + miR-21 inhibitor(the miR-21 inhibitor was admin-
istered to this group through a lentiviral vector, Genechem, 
Shanghai, China). All of the rabbits except for one in the 
RAP group survived to the end of the study. The data gen-
erated from the dead rabbit was not included in the results 
presented in this paper.
Animal model and experimental design
All the rabbits were intravenously anesthetized with 
30 mg kg−1 pentobarbital sodium before being intubated 
and placed on mechanical ventilation with a volume-cycled 
ventilator (Model HX-200, TAIMENG, Chengdu, China). 
The heart was exposed at the center of the breastbone and 
a custom-designed set of electrodes, comprising a pair 
of electrodes with a distal hook for pacing and a pair of 
electrodes was sutured to the epicardial surface of the left 
atrium. The electrodes contain an interelectrode distance of 
15 mm aligned proximally that serves for recording. The 
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distal ends of these electrodes leads were tunneled sub-
cutaneously and exposed at the animal’s back, where the 
electrodes were then connected to a pacemaker (output of 
6 V with 1.0 ms pulse duration, Guangzhou Academy of 
Sciences, China) in the jacket. The pacemaker was pro-
grammed to provide RAP at 1000 ppm, and this pacing 
rate was maintained continuously for 4 weeks with a brief 
breaking period for the measurement of electrophysiologi-
cal and mechanical parameters (Supplementary Table 1) 
[10, 26]. The rabbits in Group CR were not subjected to 
surgery while those in Group SH (sham control) experi-
enced identical surgical procedure, but no RAP. When sur-
gery was completed, the rabbits were given antibiotics and 
allowed to recover for 5 days. Postoperative care included 
the administration of antibiotics and analgesics.
MiR-control lentivirus vectors (109 TU/ml, 4 μl/day) 
and miR-21 inhibitor lentivirus vectors (109 TU/ml, 4 
μl/day) were injected 2 times/per week for 4 weeks. The 
transcript for the miR-21 inhibitor was PCR purified and 
inserted into the lentiviral vector under the control of the 
CMV promoter. The GFP reporter gene was inserted at 
the 3′ end of the miR-21 inhibitor gene. Lentiviral vectors 
pseudotyped with the VSVg coat were produced. One day 
prior to pacing, the miRNA lentiviral vectors were injected 
into the jugular vein. At the end of the experiment, all of 
the rabbits were euthanized, and the left atria were exam-
ined histopathologically and collected for mRNA and pro-
tein analysis.
Masson trichrome staining for collagen
Masson trichrome staining of the paraffin section prepared 
from the Bouin-fixed samples was performed as previously 
described [27]. Adobe Photoshop 5.5 and Scion Images 
for Windows Beta 4.0.2 software were used for quantitate 
atrial collagen content [25].
Cell culture and transfection
The experimental procedure to isolate cardiac fibroblasts 
was approved by the Animal Care Committee of Guang-
zhou, China and was performed according to the method 
of Meszaros et al. Briefly, the ventricles of 2–3 hearts from 
adult male Sprague–Dawley rats (250–300 g) were minced, 
pooled, and placed in a collagenase/protease (Sigma, St 
Louis, MO, USA) digestion solution. The cells dissociated 
in the first treatment were discarded. After three digestions 
lasting 6 min each, the cells were pooled. The debris and 
myocytes were removed by unit gravity sedimentation. The 
fibroblasts were suspended in Dulbecco’s Modified Eagle 
Medium (DMEM) containing 1 % penicillin/streptomy-
cin and 10 % fetal bovine serum. After a 60-min period 
of attachment to uncoated culture plates, those cells that 
were weakly attached or unattached were rinsed free and 
discarded. The attached cells were cultured in an incubator 
with 5 % CO2 at 37 °C. The culture medium was changed 
every other day. These cultures contained N95 % cardiac 
fibroblasts (CFs) as indicated by positive vimentin expres-
sion and negative myoactin expression. Those cells in pas-
sages 2 and 3 were used in the following studies.
Cells were plated on 60 mm2 plates at a density of 
1 × 106 cells per plate. When the cells reached 70–80 % 
confluency, they were transfected with pre-miR-21 or con-
trol pre-miR (Ambion, Austin, TX, USA) using the TransIT 
TKO transfection reagent (Mirus Bio, Madison, WI, USA). 
To investigate the role of miR-21 in TGF-β1-induced colla-
gen expression, we performed miR-21 transfection experi-
ments in CFs. For these experiments, the cells were seeded 
at a density of 2 × 104 cells/cm2 in serum-free DMEM/
F12. In this study, the cells were divided into the follow-
ing groups: cells without transfection (blank control group, 
Group CR), cells transfected with the miR-control lentivi-
ral vector (30 μM) (miR-control group, Group M), cells 
transfected with the pre-miR-21 (miR-21 over-expression) 
(30 μM) lentiviral vector (pre-miR-21 group, Group PM), 
cells treated with 10 ng/ml TGF-β1 (TGF-β1 group, Group 
T), cells treated with 10 ng/ml TGF-β1 plus the pre-miR-21 
vector (30 μM) (TGF-β1 + pre-miR-21 group, Group TP), 
and cells treated with 10 ng/ml TGF-β1 plus the miR-21 
inhibitor (30 μM) (TGF-β1 + miR-21 inhibitor group, 
Group TI).
Real‑time PCR
Total RNA was extracted with TRIzol reagent (Gibco-BRL 
Life Technologies, New York, USA). cDNA was synthe-
sized with the SYBR ExScript RT-PCR kit (TOYOBO, 
Japan) according to the protocol provided by the manu-
facturer. PCR primers for TGF-β1 (forward: 5′-ACA TTG 
ACTTCC GCA AGG AC-3′; reverse: 5′-TAG TAC ACG 
ATG GGC AGTGG-3′), Smad7 (forward: 5′-GTG GCA 
TAC TGG GAG GAGAA-3′; reverse: 5′-GAT GGA GAA 
ACC AGG GAA CA-3′), collagen I (forward: 5′-TGG 
CAA GAA CGG AGA TGAC-3′; reverse: 5′-TCC AAA 
CCA CTG AAA CCT CTG-3′), and collagen III (forward: 
5′-TTC CTT TGT GGG CTG TGT CT-3′; reverse: 5′-TTG 
GCT TCT CTC ACT TTC CAG-3′) were designed with 
Primer Express software (Applied Biosystems). GAPDH 
(forward: 5′-GCA CCG TCA AGG CTG AGA AC-3; 
reverse: 5′-ATG GTG GTG AAG ACG CCA GT-3′) was 
used as a reference to normalize the input amount of RNA 
for all samples. Real-time PCR was performed using an 
ABI7300 Real-Time PCR system (Applied Biosystems) 
with the SYBR green fluorophore. All of the reactions were 
performed in at least duplicate for every sample. Thresh-
old cycle (Ct) data were collected using the Sequence 
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Detection Software version 1.2.3 (Applied Biosystems). 
The fold change in mRNA level relative to GAPDH was 
calculated using the 2∆∆Ct method [28].
TaqMan MicroRNA Reverse transcription reactions 
and TaqMan MicroRNA quantitative polymerase chain 
reactions (qPCR) were performed to detect miR-21 and 
an endogenous control, RNA U6 small nuclear (RNU6B) 
expression using the MicroRNA TaqMan Reverse Tran-
scription Kit and the TaqMan MicroRNA Assays (Applied 
BioSystems, Carlsbad, CA, USA) according to manufac-
turer’s instructions. The miRNA detection conditions were: 
95 °C for 10 min and 40 cycles of 95 °C for 15 s, 60 °C for 
1 min. The miRNA expression levels were calculated as the 
cycle threshold (-delta CT) of miR-21 and normalized with 
an endogenous control. MiR-21 (forward: 5′-GCA CCG 
TCA AGG CTG AGA AC-3; reverse: 5′- CAG CCC ATC 
GAC TGG TG-3′) and RUN6 (forward: 5′-CTC GCT TCG 
GCA GCA CA-3; reverse: 5′- AAC GCT TCA CGA ATT 
TGC GT-3′) were used as a reference to normalize the input 
amount of RNA for all samples. Real-time PCR was per-
formed using an ABI7300 Real-Time PCR system (Applied 
Biosystems) with the SYBR green fluorophore. All of the 
reactions were performed in at least duplicate for every 
sample. Threshold cycle (Ct) data were collected using 
the Sequence Detection Software version 1.2.3 (Applied 
Biosystems). The fold change in mRNA level relative to 
GAPDH was calculated using the 2∆∆Ct method [29].
Northern blotting
RNA was extracted by standard trizol method and sus-
pended in DNAse- and RNAse-free water. Samples were 
run on 15 % 7 M urea-acrylamide gels. Electrophoresis 
was performed at 20 mA for about 3 h at room tempera-
ture. The oligonucleotides to be used as probes were pur-
chased from Sigma (Milan, Italy). After electrophoresis on 
urea-acrylamide gels, the RNA was transferred to hybond 
nylon filters at 10 V overnight at 4 °C. After the ultraviolet 
cross-linking, the filters were prehybridized in 6 X SSPE, 
5 X DENHARDT and 0.5 % SDS solution. Ten picomoles 
probes were radiolabelled using P32 γATP by standard reac-
tion at 37 °C. Microspin G25 columns (Amersham) were 
used to separate radiolabelled probe from unincorporated 
γATP. The prehybridization and hybridization were per-
formed in the same buffer, at 37 °C overnight. The filters 
were washed once in prewarmed washing solution contain-
ing 6 X SSPE and exposed in cassettes containing phos-
phor screen overnight. The signals were read by Amersham 
Typhoon 9200 phosphoimager and densitometry was per-
formed with IMAGEQUANT software (Amersham). The 
filters were stripped in a solution containing 0.2 × SSPE 
and 0.2 % SDS for 10 min at 95 °C and subsequently rehy-
bridized with another probe [30].
Luciferase reporter gene assays
To examine whether Smad7 is a valid target of miR-21, a 
single copy of the putative miR-21-recognition element 
from the 3′-UTR of the Smad7 gene was cloned into the 
GV306 plasmid vector downstream of the dual luciferase 
reporter gene (Genechem, Shanghai, China). CFs were co-
transfected with the GV306 vector containing the Smad7 
3′-UTR and the miR-21 overexpression plasmid using 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Co-
transfection with a non-targeting negative control RNA was 
performed as a control. At 48 h post transfection, the cells 
were lysed and assayed for luciferase activity with a dual-
luciferase reporter assay kit (Promega, Madison, WI, USA) 
on a luminometer (Lumat LB9507).
Immunohistochemistry
After fixed in 10 % neutral formalin for 24 h, the middle 
ring of left atrium was embedded in paraffin and cut into 
4 μm thick sections. The section was incubated with pri-
mary antibodies (goat polyclonal anti-Smad7 antibody 
from Santa Cruz Biotechnology at a 1:150 dilution) at 
4 °C overnight. Incubation with the secondary antibody 
(biotinylated rabbit anti-goat antibody also from Boster 
Biotect CO). was performed at 37 °C for 30 min. Stain-
ing was generated with the streptavidin biotin-peroxidase 
complex immunohistochemical staining kit from Boster 
Biotect CO. Negative controls were performed by leav-
ing out the primary antibody. Sections were viewed with 
400× magnification and the intensity of the collagen stain-
ing was analyzed using the IBAS2.5 Image Analytical Sys-
tem (Institute of Biomedical Engineering, Beijing, China) 
as described before (Sheng, 1995). Five random fields per 
section were analyzed to produce a single number for the 
section [31].
Immunocytochemistry
The experimental procedure was performed as described 
previously [9], the cells were incubated with a primary 
antibody (anti-vimentin, myoactin, or Smad7) (1:100) in 
5 % BSA overnight at 4 °C. The cells were then washed 
and incubated with a rhodamine-conjugated second-
ary antibody (1:500). The intensity of the Smad7 staining 
was analyzed using the IBAS2.5 Image Analytical System 
(Institute of Biomedical Engineering, Beijing, China) as 
previously described [10].
Western blot
Western blot was performed as described previously [12]. 
The primary antibodies (Santa Cruz Biotechnology) were 
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diluted as follows: TGF-β1, 1:200; Smad7, 1:250; collagen 
I, 1:200; collagen III, 1:200; and β-actin, 1:500. Horserad-
ish peroxidase–labeled secondary antibodies (Cell Signal-
ing Technology) were diluted 1:1000 with 0.2 % TBS-T 
and 1 % skim milk. The protein bands on the Western blots 
were visualized using ECL Plus (Amersham, Arlington 
Heights, IL, USA). The relative band densities were nor-
malized against β-actin.
Statistical analysis
The data are expressed as mean ± SE. ANOVA and the 
Student’s t test were used to determine statistical signifi-
cance. A two-tailed probability value of 0.05 was consid-
ered statistically significant.
Results
MiRNA‑21 expression profile in atrial 
tachypacing‑induced rabbit model of AF
As shown in Fig. 1a, qRT-PCR analysis confirmed that 
miR-21 was elevated by 4.5 times in RAP samples over 
control samples (Fig. 1a). The expression of endogenous 
miR-21 in the heart and the up-regulation of miR-21 were 
verified with Northern blot analysis (Fig. 1b, c). These find-
ings prompted us to focus on exploring the role of miR-
21 in AF and the associated atrial remodeling. Real-time 
PCR and quantitative Western blot analysis found that the 
expression of TGF-β1 mRNA and protein (Fig. 1d–f) was 
significantly higher in the left atrium of group RAP than 
with the non-paced group CR and group SH. However, the 
expression of the inhibitory Smad, Smad7, was signifi-
cantly lower in the RAP group (Fig. 1e, f). This finding fur-
ther confirmed that TGF-β1/Smad7 was involved in RAP-
induced myocardial remodeling. Furthermore, through the 
computational prediction of target genes, we identified 
Smad7 as a potential target for miR-21. These findings 
prompted us to focus on exploring the role of miR-21 in AF 
and the association with Smad7 expression.
Down‑expression of miR‑21 ameliorates myocardial 
fibrosis in vivo
On the basis of the above findings, we decided to exam-
ine whether reduced expression of miR-21 ameliorates 
myocardial fibrosis in AF. First, miR-21 inhibitor lentivi-
ral vectors were injected into the jugular vein of rabbits 2 
times per week for 4 weeks. RAP began one day after the 
injections and lasted for 4 weeks. At the end of the experi-
ment, we found that miR-21 expression was significantly 
lower in the hearts of treated animals (Fig. 2a–c, p < 0.05), 
suggesting that miR-21 inhibitor lentiviral vectors can 
inhibit miR-21 expression in the heart. Next, we found that 
the incidence of atrial fibrillation after transfection with the 
miR-21 inhibitor lentiviral vector decreased from 89 % in 
the RAP group to 50 % in the lentiviral group (8 of 9 in the 
RAP group, 5 of 10 in the RAP+miR-21 inhibitor group). 
Furthermore, as shown in Table 1 and Fig. 2e, f, RAP 
increased the hydroxyproline content, collagen I and col-
lagen III deposition, left atrial weight, and left atrial mass 
index of the animals’ hearts (Table 1). Transfection with the 
miR-21 inhibitor caused a significant decrease in hydroxy-
proline content, collagen I and collagen III deposition, left 
atrial weight, and left atrial mass index and attenuated the 
progression of RAP-induced atrial fibrosis. These data sug-
gest that RAP-induced atrial fibrosis may be ameliorated 
by blocking miR-21 in the heart.
Next, Smad7 and collagen I/III mRNA and protein 
were detected by qRT-PCR and Western blotting. Smad7 
mRNA and protein levels were significantly lower than 
the CR group (Fig. 3a–c, p < 0.05). Conversely, collagen 
I/III mRNA and protein were significantly higher in the 
RAP group than the CR group (Fig. 3f–h, p < 0.05). Fur-
thermore, immunohistochemical staining indicated that 
RAP induced the down-regulation of Smad7 (Fig. 3d, e, 
p < 0.05). More importantly, Smad7 expression increased 
after transfection with miR-21 inhibitor, whereas collagen 
I/III decreased (Fig. 3, p < 0.05). These data show that the 
miR-21 inhibitor could inhibit myocardial fibrosis by up-
regulating Smad7 expression in vivo.
Effect of TGF‑β1 on miR‑21 expression in vitro
Earlier reports have shown that miR-21 is extensively 
involved in myocardial fibrosis, and miR-21 is considered 
to be associated with TGF-β1-induced myocardial fibrosis 
[22, 32]. However, there are few reports about the role of 
miR-21 in AF. We have reported that TGF-β1 is up-regu-
lated and promotes myocardial fibrosis in AF. In this study, 
we explored the relationship between miR-21 and TGF-β1 
in cardiac fibroblasts.
First, miR-21 expression in the presence of TGF-β1 
(10 ng/ml) was examined by qRT-PCR and Northern blot. 
We found that TGF-β1 can enhance miR-21 expression 
(Fig. 4a–c, p < 0.05). Next, we investigated whether miR-
21 over-expression promoted the TGF-β1-induced expres-
sion of collagen I/III, which were detected by qRT-PCR 
and Western blot. Before treating the cells with TGF-β1, 
CFs were transfected with miR-control and miR-21 over-
expression lentiviral vectors. miR-21 over-expression 
increased collagen I/III mRNA and protein levels. Mean-
while, CFs were treated with TGF-β1, with the results indi-
cating that TGF-β1 could increase collagen I/III mRNA 
expression (Fig. 4h, i). Next, CFs were transfected with 
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miR-control and miR-21 over-expression lentiviral vectors 
before being transfected with TGF-β1 (10 ng/ml) for 48 h. 
TGF-β1 plus miR-21 overexpression enhanced collagen I/
III mRNA expression more significantly than TGF-β1 treat-
ment alone (Fig. 4h, i). Interestingly, we found that miR-21 
inhibition significantly weakened TGF-β1-induced collagen 
I/III mRNA expression in the CFs that were treated with 
TGF-β1 plus the miR-21 inhibitor. Furthermore, the effect 
on collagen I/III proteins was consistent with the effect 
on these mRNAs (Fig. 4j, k). Taken together, our results 
demonstrate that TGF-β1-induced collagen I/III expression 
might result from the expression of miR-21 in vitro.
Over‑expression of TGF‑β1 induces Smad7 
down‑regulation through miRNA‑21
Our results indicated that TGF-β1-induced collagen I/
III expression might occur through the up-regulation of 
miR-21, meanwhile we found in our previous studies that 
the over-expression of TGF-β1 induced the degradation of 
Fig. 1  MiRNA expression profiling in atrial samples from a rabbit 
model of AF. a Quantitative real-time RT-PCR (qRT-PCR) verifi-
cation of the miRNA expression profile in pacing rabbits. b Repre-
sentative Northern blot depicts the expression of miR-21 mRNA. c 
Mean miR-21 expression levels in the control group (CR), sham 
group (SH), and rapid atrial pacing group (RAP) groups. RAP caused 
a significant increase in miR-21 expression. d Quantitative analysis 
of TGF-β1 and Smad7 expression by real-time RT-PCR. The relative 
TGF-β1/Smad7 mRNA levels (TGF-β1/GAPDH or Smad7/GAPDH 
in arbitrary units) were normalized to the expression levels of group 
CR and group SH and the relative expression levels (in fold expres-
sion) were calculated. e Representative Western blot gel depicting 
the levels of TGF-β1 and Smad7 protein. f Mean TGF-β1 and Smad7 
protein levels in the control group (CR), sham group (SH), and RAP 
group (RAP) groups. RAP caused a significant increase in expression 
of TGF-β1, but decreased the expression of Smad7 (*p < 0.05 vs. CR, 
unpaired t test; n ≥ 9 independent samples for each group)
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Smad7 which may decrease the inhibitory feedback regula-
tion of TGF-β1/Smad signaling pathway, so we sought to 
determine the relationship between miR-21 and Smad7 in 
TGF-β1-induced collagen expression. According to the Tar-
getScan (http://www.targetscan.org/) and Pictar databases 
(http://pictar.mdcberlin.de/) and previous experiments, 
Smad7 is a validated target of miR-21 [25, 33]. Therefore, 
to further confirm that Smad7 is a validated miR-21 target in 
CFs, we performed luciferase reporter assays. The expres-
sion of the wild-type luciferase-Smad7-3′UTR reporter was 
remarkably lower than the mutant luciferase-Smad7-3′UTR 
reporter and control plasmid (Fig. 5a, b), suggesting that 
Smad7 is a validated miR-21 target in CFs and that miR-
21 can inhibit Smad7 expression, leading to the further 
amplification of TGF-β1 signaling. Next, we investigated 
the effect of miR-21 over-expression on Smad7 mRNA 
and protein, which were detected by RT-PCR and western 
blot. Before treatment with TGF-β1, CFs were transfected 
with the miR-control and miR-21 over-expression lenti-
viral vectors. In this assay, we found that miR-21 over-
expression decreased Smad7 mRNA levels. Next, we tested 
the effect of miR-21 overexpression on TGF-β1-induced 
Smad7 down-regulation. Prior to the transfection, we con-
firmed that TGF-β1 decreased Smad7 mRNA expression in 
CFs. Next, TGF-β1-treated CFs were transfected with the 
miR-control and miR-21 over-expression lentiviral vectors. 
The results of this assay demonstrated that miR-21 over-
expression significantly enhanced TGF-β1-induced Smad7 
Fig. 2  The effect of a miR-21 inhibitor in RAP-induced myocardial 
fibrosis in vivo. a miR-21 mRNA levels were examined by qRT-PCR. 
The miR-21 inhibitor decreased miR-21 expression in the heart of 
experimental rabbits (rabbits were treated with the miR-21 inhibi-
tor and RAP for 4 weeks). b Representative Northern blot showing 
miR-21. c Mean miR-21 expression levels in the CR group and the 
RAP+miR-21 inhibitor group. d Mean incidence of AF. In contrast 
to the RAP group (89 % incidence of AF), treatment with the miR-21 
inhibitor decreased the incidence of AF to 50 % (*p < 0.05). e Mas-
son trichrome staining of rabbit atrial samples from the CR, RAP, and 
RAP+miR-21 inhibitor groups. The myocardium was stained red and 
collagens were stained blue. Bar 50 μm. f Mean collagen content in 
the left atria of the 3 groups (n ≥ 9 per group). RAP caused signifi-
cant collagen deposition in the left atria that was attenuated by the 
miR-21 inhibitor (*p < 0.05 vs. CR, #p < 0.05 vs. RAP, unpaired t 
test; n ≥ 9 independent samples for each group)
Table 1  RAP-induced 
hydroxyproline production, and 
LAW, and LAMI
Data are mean ± SE (n ≥ 9 for each group)
LAMI left atrial mass index, LAW left atrial weight
* P < 0.05 vs group CR; # P < 0.05 vs group RAP
Parameter CR SH RAP RAP + miR-21 inhibitor
Hydroxyproline 3.24 ± 0.31 3.26 ± 0.28 6.69 ± 0.47* 3.96 ± 0.25#
Body weight (g) 2.5 ± 0.2 2.4 ± 0.3 2.4 ± 0.3 2.4 ± 0.5
LAW (mg) 0.74 ± 0.15 0.76 ± 0.11 1.12 ± 0.27* 0.85 ± 0.17#
LAMI (mg/g) 0.31 ± 0.08 0.30 ± 0.07 0.52 ± 0.12* 0.40 ± 0.09#
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down-regulation compared with the TGF-β1 group and the 
miR-control group (Fig. 5d). Interestingly, we found that 
miR-21 inhibition significantly weakened TGF-β1-induced 
Smad7 mRNA down-regulation in the CFs that treated 
with TGF-β1 plus the miR-21 inhibitor (Fig. 5d). Moreo-
ver, the effect on the Smad7 proteins was in line with the 
effect on these mRNAs (Fig. 5e, f). Immunocytochemistry 
showed that TGF-β1 decreased the nuclear and perinuclear 
accumulation of Smad7. The miR-21 inhibitor, but not pre-
miR-21, increased the accumulation of Smad7 (Fig. 5c). 
Taken together, our data show that miR-21 over-expression 
directly down-regulates Smad7 expression.
Discussion
In this study, we examined the relationship between miR-
21 and TGF-β1/Smad7 signaling in AF-induced atrial fibro-
sis. The major findings of this study include the following: 
(1) our real-time PCR and quantitative Western blot analy-
ses revealed that RAP-induced AF significantly down-reg-
ulated Smad7 expression, which was associated with an 
increase in TGF-β1 and collagen I/III; (2) the AF-induced 
up-regulation of miR-21 was negatively correlated with 
Smad7 expression; (3) in isolated adult rat cardiac fibro-
blasts, treatment with TGF-β1 caused the down-regulation 
of Smad7 expression and increased the levels of miR-21 
and collagen I/III; (4) the luciferase reporter assays sug-
gested that Smad7 is a validated miR-21 target in CFs; and 
(5) in the presence of TGF-β1, inhibiting or upregulating 
miR-21 could increase and decrease Smad7 expression, 
respectively, indicating that the TGF-β1-induced decrease 
in Smad7 expression might be mediated by miR-21. These 
results strongly suggest that the miR-21-mediated degra-
dation of Smad7 might decrease the inhibitory feedback 
regulation of TGF-β1/Smad signaling and serves as a new 
insight into the development of atrial fibrosis due to atrial 
fibrillation.
Fig. 3  Effect of the miR-21 inhibitor on RAP-induced Smad7 and 
collagen I/III expression in vivo. a Quantitative analysis of Smad7 
expression by qRT-PCR. The relative Smad7 mRNA expression ratio 
(Smad7/GAPDH in arbitrary units) in the left atria was normalized to 
the expression in group CR, and the relative expression levels (in fold 
expression) were calculated. b Representative Western blot depicts 
the expression of Smad7 protein. c Mean Smad7 protein levels in the 
CR, RAP and RAP + miR-21 inhibitor groups. The level of Smad7 
was significantly lower in the left atria of the RAP group. After 
treatment with the miR-21 inhibitor, the level of Smad7 increased 
significantly compared with the CR group and the RAP group. d 
Representative immunohistochemical staining images for Smad7 
(magnification: ×400). e Graphical representation of the abundance 
of Smad7 protein in the sections. f Quantitative analysis of the 
expression of collagen I and III transcripts by qRT-PCR. The relative 
collagen I and III mRNA levels (collagen I and III/GAPDH in arbi-
trary units) in the left atria were normalized to the levels in group CR 
and the relative expression levels (in fold expression) were calculated. 
g Representative Western blot depicts the expression of collagen I and 
III protein. h Mean collagen I and III protein levels in the CR, RAP 
and RAP + miR-21 inhibitor groups. The collagen I and III level was 
significantly higher in the left atria of the RAP group. After treatment 
with the miR-21 inhibitor, the level of collagen I and III decreased 
significantly compared with the CR and RAP group (*p < 0.05 vs. 
CR; #p < 0.05 vs. RAP, n ≥ 9 independent protein samples for each 
group)
1704 Heart Vessels (2016) 31:1696–1708
1 3
AF and atrial fibrosis
Several animal models of chronic sustained AF have been 
developed to assess the atrial electric remodeling and 
arrhythmias of AF. In AF, atrial effective refractory period 
(AERP) was decreased, and the animals became more vul-
nerable to AF [4, 34]. It has been reported that rapid pacing 
induces AF with much higher incidence at the left atrial site 
Fig. 4  Effect of miR-21 on TGF-β1-induced collagen I/III expres-
sion. a qRT-PCR demonstrating that TGF-β1 (10 ng/ml) and TGF-β1 
inhibitor(10 μg/ml) induces and decrease miR-21 expression at 48 h. 
b Representative Northern blot showing miR-21. c Values of miR-21 
expression are the mean ± SE. d Northern blot verifying the upregu-
lation of miR-21 in rats fibroblast after transfection with pre-miR-21. 
e qRT-PCR demonstrating that miR-21 levels increased in rat fibro-
blasts after transfection with pre-miR-21. f Northern blot verifying 
the down-regulation of miR-21 in rat fibroblasts after transfection 
with the miR-21 inhibitor. g qRT-PCR demonstrating that miR-21 
levels deceased in rat fibroblasts after transfection with the miR-21 
inhibitor. h, i Quantitative analysis of collagen I and III expression 
by qRT-PCR. The relative collagen I and III mRNA level (collagen I 
and III/GAPDH in arbitrary units) in the left atria was normalized to 
the expression in group CR and the relative expression levels (in fold 
expression) were calculated. j Representative Western blot depicting 
he expression of collagen I and III protein. k Mean collagen I and III 
levels in the control (CR), miR-control (M), pre-miR-21 (PM), TGF-
β1 (T), TGF-β1 + pre-miR-21 (TP) and TGF-β1 + miR-21 inhibitor 
(TI) groups (*p < 0.05 vs. CR, #p < 0.05 vs. T, unpaired t test; n = 10 
independent samples for each group)
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than at the right atrium or any other sites, partly because of 
the inhomogeneous dispersion of AERP. When atrial elec-
trical remodeling returns back to normal, the underlying 
reasons for persistent AF and structural remodeling are still 
present. Thus, atrial electrical remodeling alone is suffi-
cient to induce AF, while structural remodeling is responsi-
ble for maintaining AF [35, 36]. In this study, we have suc-
cessfully established the electrical stimulation rapid pacing 
left atrium-induced AF model. We demonstrated that RAP 
alone induced profound changes in gene expression of col-
lagens. In addition to the increase in the hydroxyproline 
content and left atrial weight, a significant deposition of 
cardiac collagen I and III was observed in the atria sub-
jected to rapid pacing.
TGF‑β1 induces myocardial fibrosis by upregulating 
miR‑21
Tachycardia-induced atrial fibrosis is a hallmark of AF-
induced structural remodeling. This condition is character-
ized by the accumulation of extracellular matrix (ECM) 
and myocardial fibrosis [10, 37]. In this study, we demon-
strated that RAP alone induced profound changes in the 
expression of collagen I/III in the heart, strongly suggesting 
that tachycardia during AF might cause atrial remodeling 
resulting from atrial fibrosis. In addition to the increase in 
hydroxyproline content and left atrial weight, a significant 
deposition of cardiac collagen I and III was observed in the 
atria subjected to rapid pacing. These results also support 
Fig. 5  Effect of miR-21 on the TGF-β1-mediated down-regulation of 
Smad7. a Alignment of hsa-miR-21 and mmu-miR-21 with human 
Smad7 3′-UTR and mouse Smad7 3′-UTR based on TargetScan and 
Pictar software (http://www.targetscan.org/ and http://pictar.mdcber-
lin.de/). Several nucleotides in the 50-region of miR-21 (human and 
mouse) contain a perfect match with the 3′-UTR sequences of the 
human and mouse Smad7 genes. b The results of luciferase reporter 
assays. c Representative immunocytochemical images of Smad7 and 
propidium iodide (PI) staining. Cardiac fibroblasts were treated with 
TGF-β1 in the presence or absence of miR-21 for 48 h. d Quantita-
tive analysis of Smad7 expression by qRT-PCR. The relative Smad7 
mRNA expression ratio (Smad7/GAPDH in arbitrary units) was nor-
malized to that of group CR and the relative expression levels (in fold 
expression) were calculated. e Representative Western blot depicting 
the expression of Smad7 protein. f Mean Smad7 protein levels in the 
control (CR), miR-control (M), pre-miR-21 (PM), TGF-β1 (T), TGF-
β1 + pre-miR-21 (TP) and TGF-β1 + miR-21 inhibitor (TI) groups 
(*p < 0.05 vs. CR, #p < 0.05 vs. T, unpaired t test; n = 10 independ-
ent samples for each group)
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our previous observations that atrial fibrosis consisting of 
collagen types I and III is a typical feature of AF.
Increasing evidence indicates that targeting TGF-β1/
Smad-specific miRNAs related to fibrosis may be a better 
approach for combating heart disease [38–40], with miR-
21 being the best characterized miRNA associated with 
TGF-β1-mediated fibrosis [41]. It reported that miR-21 is 
expressed much higher in cardiac fibroblasts and accompa-
nied by the increased expression of collagen in pathologi-
cal states of heart failure [42]. In a rat model of myocardial 
infarction, the down-regulation of miR-21 can reduce the 
degree of atrial fibrosis and the incidence of AF [43]. Adam 
recently confirmed miR-21 levels were significantly higher 
in patients with atrial fibrillation, and the up-regulation of 
miR-21 target genes can increase fibrin deposition [19]. We 
have observed previously that RAP may cause atrial fibro-
sis through the AngII/AT1 receptor–specific activation of 
the TGF-β1/Smad pathway and that TGF-β1 overexpression 
induces myocardial fibrosis in AF [10]. However, whether 
miR-21 over-expression enhanced TGF-β1-induced myo-
cardial fibrosis in AF remained elusive. In vivo, we found 
that RAP induced TGF-β1 and miR-21 up-regulation with 
the increased expression of collagen. Transfection with the 
miR-21 inhibitor, we found it reduce the incidence of AF 
and ameliorated RAP-induced atrial fibrosis. In vitro, we 
found that miR-21 over-expression increased collagen I/III 
expression and that miR-21 over-expression after treatment 
with TGF-β1 further increased collagen I/III expression. In 
addition, blocking miR-21 expression reverses the TGF-β1-
induced up-regulation of collagen I/III. Thus, our study fur-
ther suggested that miR-21 may be involved in the regula-
tion of RAP-induced myocardial fibrosis, and we speculate 
that miR-21 over-expression significantly enhances TGF-
β1-induced collagen expression.
Mechanisms underlying AF‑induced down‑regulation 
of Smad7 expression
The down-regulation of Smad7 may be key in the 
increased activation of the TGF-β1/Smad signaling path-
way that is responsible for increased atrial fibrosis during 
AF [10, 44]. Smad7 not only exhibits a protective role in 
Ang II-induced cardiac fibrosis and inflammation, but also 
possesses therapeutic potential for hypertensive cardiac 
disease [11, 16]. In our previous study, we reported that the 
overexpression of Smad7 blocked AngII-induced increases 
in collagen I synthesis and that the overexpression of TGF-
β1 decreased Smad7 expression [10]. In this study, we 
also found that RAP decreased Smad7 expression, which 
is negatively correlated with TGF-β1 and collagen I/III 
expression. This finding further confirmed that the down-
regulation of Smad7 might cause myocardial fibrosis in 
AF. miR-21 is the best characterized miRNA associated 
with TGF-β1-mediated fibrosis [41]. For example, miR-21 
and Smad7 are critical regulators of TGF-β1 signaling dur-
ing the induction of carcinoma-associated fibroblast for-
mation [33, 45, 46]. miR-21 overexpression enhances the 
TGF-β1-induced epithelial-to-mesenchymal transition by 
targeting Smad7 and aggravates renal damage in diabetic 
nephropathy. However, the regulation mechanism linking 
miR-21 and Smad7 in RAP-induced myocardial fibrosis 
was unclear. To further demonstrate our observations in 
this study and gain more information about how Smad7 is 
down-regulated during RAP, we examined growth-arrested 
adult rat fibroblast cells. Moreover, bioinformatics and the 
luciferase reporter assays showed that Smad7 is a validated 
target of miR-21. We found that miR-21 over-expression 
decreases Smad7 expression, which was similar to the 
change that occurred with TGF-β1 treatment. Furthermore, 
miR-21 over-expression significantly enhanced TGF-
β1-induced Smad7 down-regulation. Interesting, inhibit-
ing miR-21 expression weakened the TGF-β1-mediated 
down-regulation of Smad7 expression. This study further 
confirmed our previous research that the down-regulation 
of Smad7 may be responsible for RAP-induced myocar-
dial fibrosis. More interestingly, the molecular mechanism 
underlying this phenomenon is as follows: the expression 
of TGF-β1 leads to miR-21 up-regulation, and miR-21 
over-expression directly down-regulates Smad7 expres-
sion, which leads to amplification of TGF-β1 signaling and 
ultimately results in RAP-induced fibrosis. Thus, we spec-
ulate that miR-21 over-expression significantly enhances 
TGF-β1-induced collagen expression and that Smad7 can 
directly inhibit collagen expression in RAP-induced myo-
cardial fibrosis.
In summary, our data demonstrate that TGF-β1-induced 
miR-21 over-expression enhances TGF-β1-induced col-
lagens expression by directly down-regulating Smad7. 
These results may provide new insights into the mecha-
nisms underlying AF-induced atrial fibrosis and myocar-
dial remodeling and provide valuable information for novel 
therapeutic targets for AF.
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